이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Zhejiang Qianjiang Biochemical 관리

관리 기준 확인 0/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	2.1yrs

최근 관리 업데이트

Recent updates

Zhejiang Qianjiang Biochemical (SHSE:600796) Shareholders Will Want The ROCE Trajectory To Continue

May 13

There Is A Reason Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Price Is Undemanding

Feb 27

CEO

Zhejiang Qianjiang Biochemical 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Song Zhang	Deputy GM & Vice Chairman	2.1yrs	CN¥193.05k	데이터 없음
Qiang Yu	Chairman of the Supervisory Board	no data	데이터 없음	0.00046% CN¥ 17.4k
Bing Qi Zhu	Employee Supervisor	no data	데이터 없음	0.00035% CN¥ 13.2k
Zhimi Zhou	Director	2.1yrs	데이터 없음	데이터 없음
Yizheng Qiu	Independent Director	2.1yrs	CN¥46.70k	데이터 없음
Haifeng Wu	Director	2.1yrs	데이터 없음	데이터 없음
Xia Fang Zhu	Supervisor	no data	데이터 없음	데이터 없음

2.1yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 이사회: 600796 의 이사회는 경험(평균 재직 기간 2.1 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Zhejiang Qianjiang Biochemical 관리

관리 기준 확인 0/4

주요 정보

최근 관리 업데이트

Zhejiang Qianjiang Biochemical Co., Ltd, Annual General Meeting, May 10, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Zhejiang Qianjiang Biochemical Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024

Zhejiang Qianjiang Biochemical (SHSE:600796) Shareholders Will Want The ROCE Trajectory To Continue

Investor sentiment improves as stock rises 25%

First quarter 2024 earnings released: EPS: CN¥0.03 (vs CN¥0.04 in 1Q 2023)

Full year 2023 earnings: EPS misses analyst expectations

Zhejiang Qianjiang Biochemical Co., Ltd, Annual General Meeting, May 10, 2024

Investor sentiment deteriorates as stock falls 17%

Zhejiang Qianjiang Biochemical Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

There Is A Reason Zhejiang Qianjiang Biochemical Co., Ltd's (SHSE:600796) Price Is Undemanding

Investor sentiment deteriorates as stock falls 20%

Zhejiang Qianjiang Biochemical Co., Ltd to Report Fiscal Year 2023 Results on Apr 19, 2024

Third quarter 2023 earnings released: EPS: CN¥0.059 (vs CN¥0.06 in 3Q 2022)

New minor risk - Share price stability

Zhejiang Qianjiang Biochemical Co., Ltd to Report Q3, 2023 Results on Oct 27, 2023

Second quarter 2023 earnings released: EPS: CN¥0.058 (vs CN¥0.05 in 2Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.06 (vs CN¥0.001 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.05 (vs CN¥0.042 in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.02 loss in 1Q 2021)

Less than half of directors are independent

Third quarter 2021 earnings released: EPS CN¥0.001 (vs CN¥0.02 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.033 (vs CN¥0.002 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.02 (vs CN¥0.064 in FY 2019)

New 90-day low: CN¥4.66

New 90-day low: CN¥4.94

New 90-day low: CN¥5.36

Haining Guangyao Thermal Power Co., Ltd. agreed to acquire Haining Dongshan Thermoelectric Co., Ltd. from Zhejiang Qianjiang Biochemical Co., Ltd (SHSE:600796), Zhejiang Qiantangjiang Investment Development Co., Ltd. and other group of sellers for CNY 86.2 million.

New 90-day high - CN¥6.27

New 90-day high - CN¥6.05

Zhejiang Qianjiang Biochemical Co., Ltd. to Report First Half, 2020 Results on Aug 19, 2020

CEO

이사회 구성원

평균 재임 기간

평균 연령